GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 90 filers reported holding GENERATION BIO CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,807 | -99.9% | 510,354 | 0.0% | 0.28% | +19.0% |
| Q1 2023 | $2,194,522 | +9.4% | 510,354 | 0.0% | 0.23% | -7.2% |
| Q4 2022 | $2,005,691 | -26.0% | 510,354 | 0.0% | 0.25% | -26.1% |
| Q3 2022 | $2,710,000 | -19.1% | 510,354 | 0.0% | 0.34% | -13.1% |
| Q2 2022 | $3,348,000 | -10.6% | 510,354 | 0.0% | 0.39% | +2.6% |
| Q1 2022 | $3,746,000 | +3.7% | 510,354 | 0.0% | 0.38% | +11.5% |
| Q4 2021 | $3,613,000 | -71.8% | 510,354 | 0.0% | 0.34% | -54.8% |
| Q3 2021 | $12,795,000 | -7.2% | 510,354 | -0.4% | 0.75% | -5.4% |
| Q2 2021 | $13,782,000 | -5.5% | 512,349 | 0.0% | 0.79% | -2.7% |
| Q1 2021 | $14,581,000 | -1.4% | 512,349 | -1.7% | 0.82% | +1.6% |
| Q4 2020 | $14,783,000 | -5.5% | 521,460 | +3.0% | 0.80% | -6.9% |
| Q3 2020 | $15,649,000 | +47.2% | 506,273 | 0.0% | 0.86% | -5.1% |
| Q2 2020 | $10,632,000 | – | 506,273 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,279,484 | $31,379,244 | 4.86% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $3,875,415 | 0.71% |
| Artal Group S.A. | 2,814,191 | $10,666 | 0.46% |
| PFM Health Sciences, LP | 2,514,443 | $9,529,739 | 0.45% |
| Yiheng Capital Management, L.P. | 1,666,181 | $6,314,826 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 356,740 | $1,352,045 | 0.26% |
| EcoR1 Capital, LLC | 2,046,867 | $7,757,626 | 0.26% |
| Bellevue Group AG | 3,617,080 | $13,708,733 | 0.22% |
| SVB FINANCIAL GROUP | 25,034 | $94,879 | 0.18% |
| CORNERCAP INVESTMENT COUNSEL INC | 37,681 | $142,811 | 0.03% |